Moreover, ENHO’s negative correlations with other immune checkpoint molecules, such as CD276 (B7-H3) and NT5E (CD73), which are implicated in immune escape by suppressing T-cell activity and promoting regulatory T-cell (Treg) responses [29,32], further reinforce its potential anti-tumor role. The gene discussed is ENHO; the disease is neoplasm.